Sopharma Properties REIT (BUL:SFI)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 4.640
+0.320 (7.41%)
At close: May 26, 2026
Sopharma Properties REIT Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 6.41 | 6.29 | 5.93 | 5.41 | 4.81 | 4.75 |
Other Revenue | 1.04 | 1.02 | 0.95 | 0.83 | 0.66 | 0.62 |
| 7.45 | 7.3 | 6.88 | 6.23 | 5.46 | 5.37 | |
Revenue Growth (YoY | 6.66% | 6.13% | 10.38% | 14.06% | 1.67% | -4.51% |
Property Expenses | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 |
Selling, General & Administrative | 2.26 | 2.16 | 2.01 | 1.95 | 1.91 | 1.51 |
Depreciation & Amortization | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 |
Other Operating Expenses | 0.26 | 0.25 | 0.21 | 0.2 | 0.05 | 0.13 |
Total Operating Expenses | 2.55 | 2.44 | 2.24 | 2.18 | 1.98 | 1.67 |
Operating Income | 4.9 | 4.86 | 4.64 | 4.05 | 3.48 | 3.71 |
Interest Expense | - | - | -0 | -0.08 | -0.08 | -0.1 |
Interest & Investment Income | 0.04 | 0.06 | 0.02 | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | -0 | -0 | -0 |
Other Non-Operating Income | - | - | -0.01 | -0.01 | -0.01 | - |
EBT Excluding Unusual Items | 4.94 | 4.92 | 4.65 | 3.96 | 3.39 | 3.61 |
Gain (Loss) on Sale of Assets | - | - | 0 | - | 0.09 | - |
Total Insurance Settlements | - | - | 0 | 0 | 0 | - |
Asset Writedown | 2.3 | 2.26 | 3.06 | 2.09 | 1.77 | 1.03 |
Total Legal Settlements | - | - | - | - | - | 0 |
Other Unusual Items | - | - | 0 | - | - | - |
Pretax Income | 7.25 | 7.18 | 7.72 | 6.05 | 5.25 | 4.64 |
Net Income | 7.25 | 7.18 | 7.72 | 6.05 | 5.25 | 4.64 |
Net Income to Common | 7.25 | 7.18 | 7.72 | 6.05 | 5.25 | 4.64 |
Net Income Growth | -7.73% | -6.99% | 27.63% | 15.26% | 13.14% | 28.90% |
Basic Shares Outstanding | 22 | 22 | 22 | 22 | 22 | 22 |
Diluted Shares Outstanding | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Change (YoY) | - | - | - | - | - | 1.80% |
EPS (Basic) | 0.33 | 0.33 | 0.35 | 0.28 | 0.24 | 0.21 |
EPS (Diluted) | 0.33 | 0.33 | 0.35 | 0.28 | 0.24 | 0.21 |
EPS Growth | -7.73% | -6.99% | 27.63% | 15.26% | 13.14% | 26.62% |
Dividend Per Share | 0.313 | 0.307 | 0.190 | 0.082 | 0.084 | 0.085 |
Dividend Growth | 65.34% | 61.82% | 131.85% | -3.01% | -0.64% | 1.26% |
Operating Margin | 65.78% | 66.54% | 67.49% | 64.97% | 63.68% | 68.95% |
Profit Margin | 97.28% | 98.33% | 112.21% | 97.05% | 96.04% | 86.31% |
EBITDA | 4.91 | 4.86 | 4.65 | 4.05 | 3.48 | 3.71 |
EBITDA Margin | 65.84% | 66.60% | 67.54% | 65.02% | 63.72% | 69.05% |
D&A For Ebitda | 0 | 0 | 0 | 0 | 0 | 0.01 |
EBIT | 4.9 | 4.86 | 4.64 | 4.05 | 3.48 | 3.71 |
EBIT Margin | 65.78% | 66.54% | 67.49% | 64.97% | 63.68% | 68.95% |
Revenue as Reported | 9.75 | 9.56 | 9.95 | 8.33 | 7.33 | 6.46 |